XCSport体育
About Henlius
Company Profile
Corporate Culture
Honor
XCSport体育:Board of Directors
XCSport体育:Management Team
Advisory Committee
Product
Marketed Products
XCSport体育:Products in R&D
XCSport体育:Clinical Trial
Science & Technology
R&D Result
XCSport体育:Innovation Centre
XCSport体育:Technology Platform
XCSport体育:Quality Management
XCSport体育:Manufacturing
Collaborations
Investor Relations
Information Disclosure
Corporate Governance
Financial Reports
XCSport体育:Stock Info
IR Calendar
Investor Presentation
Analyst Coverage
Contact Information
Media
XCSport体育:Press Release
Multi-media
Media Reports
XCSport体育:Media Enquiry
Careers
Talent Philosophy
Staff Life
Training and Development
Job Opportunities
Contact Us
Contact Information
Customer Message
Privacy
Legal Statement
Compliance
EN
简体
EN
繁體
Home
XCSport体育:About Henlius
Company Profile
XCSport体育:Corporate Culture
Honor
XCSport体育:Board of Directors
Management Team
Advisory Committee
Product
Marketed Products
XCSport体育:Products in R&D
Clinical Trial
XCSport体育:Science & Technology
R&D Result
XCSport体育:Innovation Centre
XCSport体育:Technology Platform
XCSport体育:Quality Management
Manufacturing
Collaborations
XCSport体育:Investor Relations
Information Disclosure
Listing Documents
Announcement & Circulars
Corporate Governance
Financial Reports
Stock Info
XCSport体育:IR Calendar
Investor Presentation
Analyst Coverage
Contact Information
Media
Press Release
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
XCSport体育:Multi-media
Company
Event
Popular Science
Media Reports
XCSport体育:Media Enquiry
Careers
Talent Philosophy
Staff Life
Training and Development
Job Opportunities
Contact Us
XCSport体育:Contact Information
XCSport体育:Customer Message
Privacy
XCSport体育:Legal Statement
XCSport体育:Compliance
搜索
Be the most trusted biotech company
Press Release
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
XCSport体育:Multi-media
Company
XCSport体育:Popular Science
Highlights
Download
XCSport体育:Media Reports
Media Enquiry
2021 Q3 Milestone
Henlius half-year (H1) 2021 results
1st Anniversary of 汉曲优® China Approval
2021 Q2 Milestone
2021 Q1 Milestone
2020 Q4 Milestone
2020 Q3 Milestone
Songjiang Manufacturing Facility (Second Plant) Phase 1 Project Milestone
HLX02(汉曲优®, Trastuzumab)Commercial Launch Conference
1
2
3